Sort by
Keyphrases
Retinal pigment Epithelium
100%
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
74%
Medicare Beneficiaries
71%
Glutaredoxin
66%
P2Y12 Inhibitors
66%
Chronic Dialysis
66%
Refill Patterns
57%
Prescription Refill
57%
Hydrogen Peroxide
51%
Older Adults
47%
End-stage Kidney Disease
47%
Confidence Interval
47%
Oxidative Damage
40%
Medication Adherence
38%
Healthcare Utilization
38%
Cell Injury
37%
Oxidative Stress
35%
RTA-408
33%
Triterpenoids
33%
Glutathionylation
33%
Long-term Medication
33%
Oxidative Stress-induced Cell Death
33%
Traditional Medicine
33%
Texas
33%
COVID-19
33%
Older Adults with Diabetes
33%
Rural Communities
33%
Urban Community
33%
Ocular Diseases
33%
Non-communicable Diseases
33%
Health Disparities
33%
Oral Hypoglycemic Agents
33%
Salvianolic Acid B
33%
South Africa
33%
Medication Burden
33%
Dynamic Change
33%
Hospital Readmission
33%
Drug Burden Index
33%
Cancer Application
33%
Healthcare Expenditure
25%
Adverse Drug Events
23%
Age-related Macular Degeneration
19%
Antioxidant System
19%
Young Patients
19%
Adjusted Odds Ratio
19%
African American
19%
Adverse Clinical Outcomes
19%
All-cause Mortality
19%
Hispanic
17%
Apoptosis
17%
Medicine and Dentistry
Medicare
84%
Health Care Cost
75%
End Stage Renal Disease
66%
Odds Ratio
42%
Medication Compliance
40%
COVID-19
33%
Transcription Factor Nrf2
33%
Diabetes
33%
Health Disparity
33%
Oral Antidiabetic Agent
33%
Traditional Herbal Medicine
33%
Antioxidant
33%
Non Communicable Disease
33%
Eye Disease
33%
Adverse Drug Reaction
33%
Combination Therapy
33%
Malignant Neoplasm
33%
Health Care
31%
Cataract
16%
Prescription Medication
16%
Medicine
16%
Diabetic Retinopathy
16%
Age Related Macular Degeneration
16%
Oxidizing Agent
16%
Oxidative Stress
16%
Glaucoma
16%
Racial Disparity
15%
Health Care Utilization
15%
Hazard Ratio
13%
Antiplatelet Drug
13%
Oral
13%
Primary Outcome
13%
Mortality Rate
11%
Adverse Event
10%
Clinician
10%
Nonsteroid Antiinflammatory Agent
9%
Gabapentinoid
9%
Benzodiazepine Derivative
9%
Emergency Department
8%
Linear Regression Analysis
8%
Retrospective Cohort Study
8%
Comorbidity
8%
Diseases
8%
Sedative Agent
6%
Vertigo
6%
Pharmacokinetics
6%
Pharmacodynamics
6%
Health Care Personnel
6%
Dizziness
6%
Decision Making
6%
